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Abstract Phytolacca dioica L. leaves produce at least two type-
I ribosome-inactivating proteins. Each polypeptide chain is
subjected to different post-translational modifications giving rise
to PD-L1 and PD-L2, and PD-L3 and PD-L4, each polypeptide
pair having the same primary structure. With the aim of
exploiting the cytotoxic properties of these proteins as potential
biological phytodrugs, a gene encoding PD-L4 was designed
based on criteria expected to maximize the translation efficiency
in tomato. The gene was constructed from 18 oligonucleotides
and preliminarily expressed in Escherichia coli, using the T7
promoter system. The protein produced was insoluble and
accumulated in inclusion bodies to about 300 mg/l of culture.
Ribosome-inactivating activity was generated by controlled
oxidation of the reduced and denatured protein. The recombinant
protein was indistinguishable from natural PD-L4 as isolated
from leaves of Phytolacca dioica, in both catalytic activity and
primary structure.
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1. Introduction
Ribosome-inactivating proteins (RIPs) [1] are N-L-glycosid-
ases which remove a speci¢c adenine residue of the RNA of
the large ribosomal subunit (A4324 in the 28S rat rRNA) [2^4].
Two classes of RIPs have been described: type-I RIPs, con-
taining a single chain, enzymatically active, and type-II RIPs,
made of two chains, one catalytically active, and similar to
type-I RIPs, the other containing a cell binding domain [1].
Thus, whereas type-II RIPs are generally extremely toxic to
many cell types, type-I RIPs are less toxic, in the absence of a
system to enter the cell. Obviously, also type-I RIPs are highly
cytotoxic once inside the cell.
Thus, the isolation of RIPs, especially type-I RIPs, is a
potential tool (i) for the development of immunotoxins for
tumor therapy [5], (ii) for their use as natural phytodrugs
[6,7], and (iii) for the production of transgenic plants endowed
with speci¢c parasite resistance [8].
Leaves of Phytolacca dioica produce several RIPs. Recently
(Di Maro et al., submitted), four new type-I RIPs have been
isolated and characterized, and named PD-L1, PD-L2, PD-
L3, and PD-L4, in decreasing molecular weight.
PD-L1^3 were found to be extensively glycosylated, where-
as PD-L4 did not apparently contain any sugar moiety. More-
over, the total amino acid sequence of PD-L4 has been deter-
mined [9] and found to be homologous to PAP, PAPII, and
PAP-S [10], and to PAP-C [11].
In the light of a potential use of P. dioica RIPs to construct
single-chain immunotoxins [12,13] and/or transgenic plants
[8], we decided to construct a synthetic gene encoding P. dio-
ica PD-L4, to facilitate further studies on its mechanism of
action, and to express the recombinant protein in Escherichia
coli.
The choice of PD-L4, instead of the other RIPs puri¢ed
from leaves of P. dioica, was primarily based on the apparent
absence of glycosylation, although it has already been shown
that the presence of carbohydrates does not interfere with the
catalytic activity and the stability of RIPs [1]. However, this
should facilitate its heterologous expression both in prokary-
otic and eukaryotic systems.
The choice of synthesizing the gene, instead of isolating a
cDNA from a P. dioica leaf library, is motivated by the ad-
vantages given by a designed gene, which contains as many
unique restriction sites as possible, compared to its natural
counterpart, and uses a speci¢c codon usage. Thus, based
on the characteristics above, a synthetic gene is suitable for
modular mutagenesis experiments, and is optimized for heter-
ologous expression into selected host cells.
2. Materials and methods
2.1. Proteins
Native PD-L4 was puri¢ed as described (Di Maro et al., submitted)
from leaves of P. dioica L. harvested at the Orto Botanico of the
University of Naples Federico II.
2.2. Materials and general procedures
Plasmid pUC118 and E. coli strain JM101 were purchased from
Boehringer; expression vector pET22b(+) and E. coli strain
BL21(DE3) from AMS Biotechnology; labelled oligonucleotides
from Amersham; reagents for PCR from Perkin-Elmer Cetus. The
Gene-Clean kit for elution of DNA fragments from agarose gel was
obtained from Bio 101. Enzymes, including restrictases, and other
reagents for DNA manipulation were from Promega Biotech. The
oligonucleotides for the synthesis of the cDNA coding PD-L4 were
synthesized at the Stazione Zoologica ‘A. Dohrn’ (Naples, Italy).
Bacterial cultures, plasmid puri¢cations and transformations were
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performed according to Sambrook [14]. Single- and double-stranded
DNA were sequenced with the dideoxy method of Sanger [15] carried
out with a Sequenase Sequencing Kit and labelled nucleotides from
Amersham.
2.3. Design of the gene encoding PD-L4
PD-L4 contains 261 amino acid residues [9]. A cDNA encoding the
protein was designed from its amino acid sequence; the procedure of
Libertini and Di Donato [16] was followed with the aim of: (i) in-
cluding the maximum number of unique restriction sites, useful for
future modular mutagenesis, and (ii) privileging vegetable species pre-
ferred codons [17]. The prokaryotic cloning vector (see below), re-
quired that the gene had to be inserted between EcoRI and XbaI sites.
The cDNA sequence was thus modi¢ed, to allow its polar insertion
into the cloning vector, by the addition of extra sequences which
could be cleaved by EcoRI and NdeI (the latter needed for the polar
insertion into the prokaryotic expression vector) at the 5P end, and
XbaI (at the 3P end). The above mentioned procedure resulted in the
design of an 816 bp cDNA (Fig. 1). The sequence was then divided
into 18 oligonucleotides, ranging in length from 55 to 63 bases, for a
total of 1075 bases. This number is about 34% lower than the number
of bases required by other methodologies of total synthesis based on
ligation of complementary oligonucleotides. The overlaps between the
oligonucleotide pairs were 14^18 bases, with Tm values of 44^46‡C.
2.4. Cell-free protein synthesis inhibition assay
Inhibition of protein synthesis was determined using a cell-free
rabbit reticulocyte lysate translation system (Promega, WI). RIPs
were mixed in a volume of 15 Wl with rabbit reticulocyte lysate
(10.5 Wl), a mixture of all amino acids (minus methionine) at 20 WM
¢nal concentration, 1 Wl of 10 mCi/ml [35S]methionine, and luciferase
RNA as substrate (0.6 Wg). The reaction mixture was incubated at
30‡C for 1 h. 2 Wl was withdrawn and the reaction stopped by addi-
tion of 98 Wl of 1 M NaOH containing 2% H2O2. The translation
product was precipitated with 900 Wl of ice-cold 25% trichloroacetic
acid and 2% casamino acids as carrier for 30 min on ice. The radio-
labeled proteins were collected on glass ¢ber ¢lters, washed with 5%
trichloroacetic acid and then with acetone, dried, and counted using a
Beckman LS 1701 scintillation counter. Inhibition of protein synthe-
sis, expressed as the percentage of radiolabeled incorporation into
translation products of samples containing RIPs compared to un-
treated samples, was measured at least in duplicate. The procedure
as described allowed the detection of at least 5% inhibition.
IC50 values were calculated from semi-logarithmic plots constructed
using a non-linear ¢tting procedure, using the program Regression
(Blackwell, Oxford).
2.5. In vitro assay for N-glycosidase activity (aniline assay)
Isolated Saccharomyces cerevisiae ribosomes [18] (34 Wg) were in-
cubated with the RIP (13 Wg) at 30‡C for 30 min in a total volume of
22 Wl of 1.5 mM Tris-HCl pH 7.5, 1.5 mM Na phosphate pH 7.5, 22.5
mM NaCl, 1.5 mM MgCl2, 1.5 mM EDTA, 75 WM DTT, 6% glyc-
erol. Control reactions lacking RIPs were similarly incubated. ATP, at
a ¢nal concentration of 1 mM, was added to the assay mixture. After
incubation, the samples were diluted with 10 Wl of 10% SDS and 170
Wl of sterile water; RNA was extracted [19] and lyophilized. Aniline
treatment of RNA and electrophoresis in agarose/formamide gels
were carried out as described previously [20]. Gels were loaded with
identical RNA samples treated and untreated with aniline, stained in
ethidium bromide and photographed on a UV transilluminator. N-L-
Glycosidase activity was evidenced by the presence of a ca. 370 nu-
cleotide fragment released from 26S rRNA [21].
2.6. Other methods
Protein sequence determinations were performed on an Applied
Biosystems sequencer model 473A, connected on-line with the
HPLC apparatus for identi¢cation of phenylthiohydantoin deriva-
tives.
The electrospray mass spectrometric analyses were performed on a
VG Bio Q mass spectrometer (VG Analytical).
3. Results and discussion
3.1. Synthesis and cloning of the gene for PD-L4
The procedure was essentially that described by Di Donato
et al. [22]. The two primer oligonucleotides A and B (Fig. 1)
were used, at a concentration of 0.1 mM, for the synthesis of
a central template. A total of 1/20 of this PCR mixture was
used as a template for the subsequent PCR experiments.
After each PCR run, 1/20 aliquot of the reaction mixture
was withdrawn and added to fresh PCR bu¡er and dNTPs.
New primers (i.e. C and D in the second PCR round) were
then added at 1 mM ¢nal concentration, along with 1 unit of
Taq polymerase, and the new elongation continued for addi-
tional 20 cycles. The same procedure was repeated until the
most extreme primers, i.e. S and T, were used.
An aliquot of the puri¢ed cDNA obtained by the PCR
procedure was digested with EcoRI and XbaI, and ligated to
the cloning vector pUC118, previously digested with the same
enzymes. The ligation mixture was used to transform compe-
tent JM101 cells, plated onto LB/ampicillin plates. Sequencing
of the plasmid DNA of recombinant clones revealed that the
inserted sequence was correct and corresponded to the gene as
designed.
The sequence coding for PD-L4 was excised from the clon-
ing vector using NdeI and HindIII, and ligated to the expres-
sion vector pET22b(+), previously cut with the same enzymes.
The ligation mixture was used to transform competent JM101
cells, plated onto LB/ampicillin plates. Several clones were
subsequently grown in liquid media (supplemented with 50
Wg/ml ampicillin), and their plasmid DNA was sequenced.
The inserted sequence was correct, and located, as expected,
between NdeI and HindIII sites of the vector. The recombi-
nant plasmid was named pPD4.
3.2. Expression of rPD-L4 from E. coli
Plasmid pPD4 (20 ng) was used to transform competent
BL21(DE3) cells, plated onto LB/ampicillin plates. One re-
combinant clone was grown in 5 ml of TB medium, supple-
mented with ampicillin, at 37‡C up to OD600nm = 0.7. This
culture was used to inoculate 100 ml of TB supplemented
with 50 Wg/ml ampicillin, and grown at 37‡C until optical
reading was 4.0 at 600 nm. Then IPTG was added to 0.4
mM ¢nal concentration, and growth continued overnight, at
37‡C. An SDS-PAGE analysis of induced and non-induced
cells extracted in electrophoresis loading bu¡er showed that
a protein with a molecular mass of about 29 kDa, the ex-
pected molecular size of recombinant PD-L4, was produced
only in the induced cells (Fig. 2).
3.3. Puri¢cation and characterization of recombinant
PD-L4
Cells from 100 ml of induced culture were harvested by
centrifugation for 10 min at 5520Ug, at 4‡C, suspended in
10 ml of 50 mM Tris-HCl pH 8.0 containing 1 mM
Na2EDTA pH 8.0 (TE) and 20% sucrose, and kept for
15 min on ice. An equal volume of ice-cold water was added,
the sample was returned to ice for 15 min, and then centri-
fuged at 17 400Ug for 10 min. The pellet was suspended in
10 ml of TE containing 0.25 mg/ml lysozyme, and kept on ice
for 30 min. Cells were disrupted by sonication (10U1 min
cycle, on ice). The insoluble fraction was separated from the
soluble fraction by centrifugation at 17 400Ug for 20 min, at
4‡C. SDS-PAGE analysis of the soluble and insoluble frac-
tions (data not shown) revealed that the protein of interest
was present only in the insoluble fraction, hence presumably
contained in cell inclusion bodies. Yields were about 0.3 mg of
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protein/ml of bacterial culture, on the basis of a densitometric
scanning of the electrophoretic pro¢le.
The insoluble fraction after sonication was suspended in 20
ml of TE, containing 2% Triton X-100 and 2 M urea, and
sonicated (5U1 min cycle, on ice). Pellet was recovered by
centrifugation at 17 400Ug for 20 min, at 4‡C. This procedure
was repeated (usually twice) until a clear supernatant was
obtained, and repeated two more times after suspending the
pellet in TE, without any Triton X-100 and urea.
The insoluble material was dissolved in 2 ml of 0.1 M Tris-
HCl, pH 8.0, containing 6 M guanidine-Cl, 5 mM Na2EDTA,
and incubated overnight at 4‡C. Total reduction of the pro-
teins present in the mixture was achieved by adding solid
reduced glutathione at 0.1 M ¢nal concentration, and bring-
ing the pH to 8.4 by small additions of 5 M NaOH. The
solution was kept under an N2 barrier for 2.5 h at room
temperature.
Renaturation of the proteins was obtained by dilution of
the reduction mixture in the required amount of 10 mM Na
phosphate, containing 0.4 M L-arginine, 0.6 mM oxidized glu-
tathione, and 3 mM reduced glutathione, brought to pH 8.4,
to a ¢nal recombinant protein concentration of 0.07 mg/ml.
After protein addition the solution was purged with N2, and
incubated for 24 h at room temperature.
Precipitates formed during incubation were removed by
centrifugation at 22 100Ug for 20 min, at 4‡C. On the basis
of a densitometric scanning of the electrophoretic pro¢le of an
SDS-PAGE analysis of the soluble and insoluble fractions
(data not shown) it can be estimated that about 50% of the
protein of interest is present in almost pure form in the solu-
ble fraction, whereas the remaining 50% can be found in the
precipitate, presumably consisting of misfolded forms of rPD-
L4.
The supernatant was concentrated to 10 ml by ultra¢ltra-
tion using YM-3 membranes, and dialyzed against 5 mM
sodium phosphate pH 7.2, at 4‡C. This protein preparation
was loaded in three consecutive runs on a 1 ml Source 15S
(Pharmacia) cation exchange column, equilibrated in 5 mM
sodium phosphate pH 7.2. The column was washed, at 1 ml/
min, with the same bu¡er, and eluted by increasing the NaCl
concentration (Fig. 3). The eluted protein peaks were collected
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Fig. 1. Sequence of the synthetic gene encoding rPD-L4. The underlined nucleotides indicate the sequences recognized by EcoRI and NdeI
(double underlined), at 5P, and HindIII, at 3P, respectively. Arrows (D) and italic letters indicate the sequence of the oligonucleotides used in
the synthesis of the gene.
Fig. 2. SDS-PAGE electrophoresis in 15% polyacrylamide gels of in-
duced and non-induced cells carried out under reducing conditions.
Cell lysates from non-induced (lane 4) and induced (lane 5) E. coli
clones harboring plasmid pPD4. In lane 1 non-transformed E. coli
BL21(DE3) cells, in lane 2 natural PD-S2 (from seeds of P. dioica),
and in lane 3 a mixture of PD-L1, 2, 3, and 4, are run as a control.
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as indicated in Fig. 3, dialyzed and lyophilized. Peak A (the
£ow-through peak) was found to contain no protein material,
as judged by its UV spectrum, and discarded. Peak B (about
10% of peak C) and peak C were analyzed by SDS-PAGE, as
shown in the inset of Fig. 3. The electrophoretic analysis
revealed that both peaks contained a homogeneous protein,
with the same molecular size as PD-L4, under non-reducing
conditions. The protein material in peak B was subjected to
electrospray mass spectrometry. The results of the analysis
showed that the sample contained a heterogeneous mixture
of protein species whose molecular mass corresponded to
that of natural PD-L4, and to that of natural PD-L4 with
an extra methionine, linked to one or two glutathione moi-
eties. These species presumably represented refolding inter-
mediates of the reoxidation procedure, and thus they were
not further analyzed.
Sequence analyses of the ¢rst 13 residues of the recombi-
nant protein in peak C indicated (data not shown) that two
sequences were present, both containing the N-terminal se-
quence of natural PD-L4. In the ¢rst sequence (80%) the N-
terminal residue of the protein was methionine, followed by
the ¢rst 12 residues of PD-L4, whereas in the second sequence
(20%), the N-terminal residue was valine, followed by the ¢rst
11 residue of natural PD-L4. Thus, the material in peak C is
recombinant PD-L4, but it is heterogeneous, containing
mainly an unprocessed sequence, with an extra methionine
at the N-terminus.
Mature recombinant PD-L4 was obtained by removing the
Met(31) residue using an aminopeptidase from Aeromonas
proteolytica. Protein material in peak C was dissolved at
13.7 WM ¢nal concentration in 5 mM sodium phosphate pH
7.2, containing 10 WM zinc sulfate, and incubated with Aero-
monas aminopeptidase (13.7 nM) for 72 h at 37‡C. The en-
zyme was then inactivated by addition of EDTA (20 mM),
and dialysed against 5 mM sodium phosphate pH 7.2. Se-
quence analyses after aminopeptidase treatment indicated
that more than 96% of N-terminal methionine had been re-
moved.
A sample of mature rPD-L4 was subjected to electrospray
mass spectrometry. The average molecular mass of the protein
was found to be 29 140.48 þ 1.56 Da, i.e. the mass of natural
PD-L4 as calculated from its amino acid composition.
The recombinant protein was also characterized for its en-
zymic properties, by determining (i) its ability to remove a
speci¢c adenine residue of the RNA of the large subunit of
S. cerevisiae ribosomes in a classical aniline assay, and (ii) the
value of its IC50 in a cell-free protein synthesis inhibition
assay. From the data in Table 1, rPD-L4 was found to be
virtually indistinguishable from the natural protein in its ac-
tivity on intact ribosomes and in its ability to inhibit protein
synthesis.
3.4. Concluding remarks
The procedure described for the production of recombinant
rPD-L4 is easy and e¡ective, with a yield of about 100 mg of
pure recombinant protein per liter of bacterial culture. The
recombinant protein is undistinguishable in its catalytic activ-
ity from the protein isolated from P. dioica leaves. Moreover,
the present report has con¢rmed that the T7 expression sys-
tem [23] is an e¡ective system for expressing toxic proteins,
especially because, as in the present case, recombinant pro-
teins are sequestered into inclusion bodies.
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